Vascular endothelial growth factor (VEGF) and its role in the central nervous system: A new element in the neurotrophic hypothesis of antidepressant drug action
Authors:
- 1 February 2012
- journal article
- review article
- Published by Elsevier in Neuropeptides
- Vol. 46 (1) , 1-10
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- NGF activation of TrkA induces vascular endothelial growth factor expression via induction of hypoxia-inducible factor-1αMolecular and Cellular Neuroscience, 2011
- Mechanisms of resistance to antiangiogenesis therapyEuropean Journal of Cancer, 2010
- Murine Neural Stem/Progenitor Cells Protect Neurons against Ischemia by HIF-1α–Regulated VEGF SignalingPLOS ONE, 2010
- Influence of Vascular Endothelial Growth Factor Variation on Human Hippocampus MorphologyBiological Psychiatry, 2008
- Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampusProceedings of the National Academy of Sciences, 2008
- Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effectsBrain Research Bulletin, 2008
- VEGF as a potential target for therapeutic intervention in depressionCurrent Opinion in Pharmacology, 2008
- Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibitionCellular Signalling, 2007
- VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressantsProceedings of the National Academy of Sciences, 2007
- VEGF receptor signalling ? in control of vascular functionNature Reviews Molecular Cell Biology, 2006